Mona A. Kamel

Serum matrix metalloproteinase-9 (MMP9) and amyloid-beta protein precursor (APP) as potential biomarkers in children with Fragile-X syndrome: A cross sectional study.

Mohamed H.Y. Bekheet, Lamiaa A. Mansour, Rasha H. Elkaffas, 2023, Clinical Biochemistry.